Here you’ll find our latest quarterly results, corporate reports, economic statement and By the Numbers report builder. You can also access reports from previous years.

Results alert

Receive an alert when we release our quarterly and annual results.

Sign up

Q4 2022 results


86% Return to work at 100% pre-injury earnings within 12 months*

Return to work at 100% pre-injury earnings within 12 months*

In Q4, 86.1% of people with workplace injuries or illnesses returned to work with no wage loss within 12 months, excluding those with COVID-19 claims.

Service timeliness 96% Decisions made within 10 business days 77% Claims paid within 15 days

Service timeliness

Eligibility decision timeliness improved to 96% in Q4, meeting the 2022 target. Decisions on lost-time claims specifically continued to be more timely (97%). Payment timeliness also achieved its 2022 target in Q4.


Registered claim volume* 1% higher than Q4 2021

Registered claim volume*

The number of Schedule 1 claims registered in Q4, 49,093, was comparable to Q4 2021, 48,783.

Appeals total allowance rate 30%

Appeals total allowance rate

The percentage of appeal issues that were allowed or allowed in part remained within the expected range.


Average composite duration in days* 64.5 Days (excluding COVID-19 claims)

Average composite duration in days*

Durations measure the time that claims continue to require benefits. They continued to improve in Q4 – average composite duration decreased for the sixth quarter in a row.

Sufficiency Ratio 118.2%

Sufficiency Ratio

The Sufficiency Ratio was lower than it was at year-end 2021 because of the distribution of surplus funds issued to businesses in April.


Net assets $5.4 billion in reserve

Net assets

Like the Sufficiency Ratio, our net assets on a sufficiency ratio basis decreased compared to year-end 2021 because of the rebate of surplus funds.

Percentage of people with a permanent impairment* 7.7%

Percentage of people with a permanent impairment*

The percentage of people with workplace injuries or illnesses who experienced permanent impairment increased from 6.7% in Q3 and remained above the 6.0% benchmark.


*Schedule 1 only

See a glossary of terms used in our reporting.

Past results

Learn about the WSIB Board of Directors

If you have questions about the WSIB’s corporate reporting, please contact corporatereports@wsib.on.ca.